Latest & greatest articles for adverse events

The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on adverse events or other clinical topics then use Trip today.

This page lists the very latest high quality evidence on adverse events and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.

What is Trip?

Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.

Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.

As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.

For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com

Top results for adverse events

181. Risk of myocardial infarction in patients with HIV infection exposed to specific individual antiretroviral drugs from the 3 major drug classes: the data collection on adverse events of anti-HIV drugs (D:A:D) study Full Text available with Trip Pro

Risk of myocardial infarction in patients with HIV infection exposed to specific individual antiretroviral drugs from the 3 major drug classes: the data collection on adverse events of anti-HIV drugs (D:A:D) study BACKGROUND. The risk of myocardial infarction (MI) in patients with human immunodeficiency virus (HIV) infection has been assessed in 13 anti-HIV drugs in the Data Collection on Adverse Events of Anti-HIV Drugs (D:A:D) study. METHODS. Poisson regression models were adjusted

2010 EvidenceUpdates

182. Systematic review: Adding atypical antipsychotics to antidepressants increases response in treatment-resistant major depression but increases discontinuation as a result of adverse events

Systematic review: Adding atypical antipsychotics to antidepressants increases response in treatment-resistant major depression but increases discontinuation as a result of adverse events Adding atypical antipsychotics to antidepressants increases response in treatment-resistant major depression but increases discontinuation as a result of adverse events | BMJ Evidence-Based Medicine We use cookies to improve our service and to tailor our content and advertising to you. You can manage your (...) to antidepressants increases response in treatment-resistant major depression but increases discontinuation as a result of adverse events Article Text Therapeutics Systematic review Adding atypical antipsychotics to antidepressants increases response in treatment-resistant major depression but increases discontinuation as a result of adverse events Gabor I Keitner Gabor I Keitner Department of Psychiatry and Human Behavior, Warren Alpert Medical School of Brown University, Providence, RI, USA; GKeitner

2010 Evidence-Based Medicine

183. Anhedonia predicts adverse cardiac events in people with acute coronary syndromes Full Text available with Trip Pro

Anhedonia predicts adverse cardiac events in people with acute coronary syndromes Anhedonia predicts adverse cardiac events in people with acute coronary syndromes | Evidence-Based Mental Health We use cookies to improve our service and to tailor our content and advertising to you. You can manage your cookie settings via your browser at any time. To learn more about how we use cookies, please see our . Log in using your username and password For personal accounts OR managers of institutional (...) accounts Username * Password * your user name or password? Search for this keyword Search for this keyword Main menu Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? You are here Anhedonia predicts adverse cardiac events in people with acute coronary syndromes Article Text Prognosis Anhedonia predicts adverse cardiac events in people with acute coronary syndromes Statistics from Altmetric.com Question

2010 Evidence-Based Mental Health

184. Adverse event profile of tramadol in recent clinical studies of chronic osteoarthritis pain

Adverse event profile of tramadol in recent clinical studies of chronic osteoarthritis pain Adverse event profile of tramadol in recent clinical studies of chronic osteoarthritis pain Adverse event profile of tramadol in recent clinical studies of chronic osteoarthritis pain Langley PC, Patkar AD, Boswell KA, Benson CJ, Schein JR CRD summary This review assessed the safety of long-acting formulations of tramadol hydrochloride in the treatment of chronic osteoarthritis pain and concluded (...) that differences in formulations may influence rates of adverse events. However, these differences should be interpreted with caution. Potential bias in the review, heterogeneity among studies and their unclear quality, support the authors' recommendation to interpret the findings with caution. Authors' objectives To assess the safety of various long-acting formulations of tramadol hydrochloride in the treatment of chronic osteoarthritis pain. Searching MEDLINE and EMBASE were searched between 1997 and 2008

2010 DARE.

185. Meta-analysis of the role of high-dose statins administered prior to percutaneous coronary intervention in reducing major adverse cardiac events in patients with coronary artery disease

Meta-analysis of the role of high-dose statins administered prior to percutaneous coronary intervention in reducing major adverse cardiac events in patients with coronary artery disease Untitled Document The CRD Databases will not be available from 08:00 BST on Friday 4th October until 08:00 BST on Monday 7th October for essential maintenance. We apologise for any inconvenience.

2010 DARE.

186. Adverse events associated with testosterone administration. Full Text available with Trip Pro

Adverse events associated with testosterone administration. Testosterone supplementation has been shown to increase muscle mass and strength in healthy older men. The safety and efficacy of testosterone treatment in older men who have limitations in mobility have not been studied.Community-dwelling men, 65 years of age or older, with limitations in mobility and a total serum testosterone level of 100 to 350 ng per deciliter (3.5 to 12.1 nmol per liter) or a free serum testosterone level of less (...) than 50 pg per milliliter (173 pmol per liter) were randomly assigned to receive placebo gel or testosterone gel, to be applied daily for 6 months. Adverse events were categorized with the use of the Medical Dictionary for Regulatory Activities classification. The data and safety monitoring board recommended that the trial be discontinued early because there was a significantly higher rate of adverse cardiovascular events in the testosterone group than in the placebo group.A total of 209 men (mean

2010 NEJM Controlled trial quality: uncertain

187. Adverse events associated with nicotine replacement therapy (NRT) for smoking cessation: a systematic review and meta-analysis of one hundred and twenty studies involving 177,390 individuals

Adverse events associated with nicotine replacement therapy (NRT) for smoking cessation: a systematic review and meta-analysis of one hundred and twenty studies involving 177,390 individuals Untitled Document The CRD Databases will not be available from 08:00 BST on Friday 4th October until 08:00 BST on Monday 7th October for essential maintenance. We apologise for any inconvenience.

2010 DARE.

188. Meta-analysis of adverse cardiovascular events associated with echocardiographic contrast agents

Meta-analysis of adverse cardiovascular events associated with echocardiographic contrast agents Untitled Document The CRD Databases will not be available from 08:00 BST on Friday 4th October until 08:00 BST on Monday 7th October for essential maintenance. We apologise for any inconvenience.

2010 DARE.

189. Predicting major adverse events after cardiac surgery in children

Predicting major adverse events after cardiac surgery in children PEDSCCM.org Criteria abstracted from series in Review Posted: founded 1995 Questions or comments?

2009 PedsCCM Evidence-Based Journal Club

190. Adverse events after outpatient colonoscopy in the medicare population. (Abstract)

Adverse events after outpatient colonoscopy in the medicare population. Although use of colonoscopy has increased substantially among elderly Medicare beneficiaries, no one has described colonoscopy-related adverse events in a representative sample of Medicare patients.To determine risk for adverse events after outpatient colonoscopy in elderly patients.Population-based, matched cohort study.Surveillance, Epidemiology, and End Results cancer registry areas.Random 5% sample of Medicare (...) . Logistic regression was used to estimate adjusted predictive risks for adverse events and to assess whether these events varied by age, comorbid conditions, or type of colonoscopy.Persons undergoing colonoscopy had a higher risk for adverse gastrointestinal events than their matched group. Rates of adverse events after colonoscopy increased with age. Patients having polypectomy had higher risk for all adverse events compared with their matched group and with the screening and diagnostic colonoscopy

2009 Annals of Internal Medicine

191. Effect of an electronic medication reconciliation application and process redesign on potential adverse drug events: a cluster-randomized trial Full Text available with Trip Pro

Effect of an electronic medication reconciliation application and process redesign on potential adverse drug events: a cluster-randomized trial Medication reconciliation at transitions in care is a national patient safety goal, but its effects on important patient outcomes require further evaluation. We sought to measure the impact of an information technology-based medication reconciliation intervention on medication discrepancies with potential for harm (potential adverse drug events [PADEs

2009 EvidenceUpdates Controlled trial quality: predicted high

192. Effect of a pharmacist on adverse drug events and medication errors in outpatients with cardiovascular disease Full Text available with Trip Pro

Effect of a pharmacist on adverse drug events and medication errors in outpatients with cardiovascular disease Adverse drug events and medication errors are threats to quality care. Inpatient studies suggest that a pharmacist may reduce these events, but outpatient studies have not been forthcoming.We conducted a pooled analysis of 2 randomized controlled trials to determine the effect of pharmacist intervention on adverse drug events and medication errors. We studied 800 outpatient cases (...) of hypertension stratified into complicated (n = 535) and uncomplicated (n = 265). Patients in the complicated stratum had heart failure or other cardiovascular complication. Computer programs examined 1-year electronic record data to identify events classified as adverse drug events and preventable or potential adverse drug events. Medication errors included preventable and potential adverse drug events.Of the 800 participants (mean [SD] age, 59 [10] years), 484 (90.5%) and 258 (97.4%) participants remained

2009 EvidenceUpdates Controlled trial quality: uncertain

193. Usefulness of electrocardiographic and echocardiographic left ventricular hypertrophy to predict adverse events in patients with a first non-ST-elevation acute myocardial infarction (Abstract)

Usefulness of electrocardiographic and echocardiographic left ventricular hypertrophy to predict adverse events in patients with a first non-ST-elevation acute myocardial infarction Left ventricular hypertrophy (LVH) portends a worse outcome after non-ST-elevation acute myocardial infarction (NSTEMI). However, its definition has varied and the incremental prognostic information provided by echocardiography has been unclear. Different electrocardiographic and echocardiographic criteria for LVH (...) were compared for their ability to predict in-hospital complications in 451 consecutive patients with a first NSTEMI, 337 of whom had a reliable echocardiogram. Five to 8% had LVH using Sokolow-Lyon or Cornell (voltage or product) criteria on admission; 15%, using either electrocardiographic criteria; and 24%, using echocardiography. LVH predicted the occurrence of adverse events (death, reinfarction, or severe angina or heart failure), with the strongest association found for the Cornell product

2009 EvidenceUpdates

194. Multiple antipsychotic use associated with metabolic and cardiovascular adverse events in children and adolescents

Multiple antipsychotic use associated with metabolic and cardiovascular adverse events in children and adolescents Multiple antipsychotic use associated with metabolic and cardiovascular adverse events in children and adolescents | Evidence-Based Mental Health We use cookies to improve our service and to tailor our content and advertising to you. You can manage your cookie settings via your browser at any time. To learn more about how we use cookies, please see our . Log in using your username (...) and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? Search for this keyword Search for this keyword Main menu Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? You are here Multiple antipsychotic use associated with metabolic and cardiovascular adverse events in children and adolescents Article Text Aetiology Multiple antipsychotic use

2009 Evidence-Based Mental Health

195. Review: formoterol increases serious adverse events in children and adults with chronic asthma

Review: formoterol increases serious adverse events in children and adults with chronic asthma Review: formoterol increases serious adverse events in children and adults with chronic asthma | BMJ Evidence-Based Medicine We use cookies to improve our service and to tailor our content and advertising to you. You can manage your cookie settings via your browser at any time. To learn more about how we use cookies, please see our . Log in using your username and password For personal accounts (...) OR managers of institutional accounts Username * Password * your user name or password? Search for this keyword Search for this keyword Main menu Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? You are here Review: formoterol increases serious adverse events in children and adults with chronic asthma Article Text Therapeutics Review: formoterol increases serious adverse events in children and adults

2009 Evidence-Based Medicine

196. Review: daily salmeterol increases non-fatal serious adverse events in chronic asthma

Review: daily salmeterol increases non-fatal serious adverse events in chronic asthma Review: daily salmeterol increases non-fatal serious adverse events in chronic asthma | BMJ Evidence-Based Medicine We use cookies to improve our service and to tailor our content and advertising to you. You can manage your cookie settings via your browser at any time. To learn more about how we use cookies, please see our . Log in using your username and password For personal accounts OR managers (...) of institutional accounts Username * Password * your user name or password? Search for this keyword Search for this keyword Main menu Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? You are here Review: daily salmeterol increases non-fatal serious adverse events in chronic asthma Article Text Therapeutics Review: daily salmeterol increases non-fatal serious adverse events in chronic asthma Statistics from

2009 Evidence-Based Medicine

197. Short term use of antipsychotics increases the risk of serious adverse events in elderly people with dementia

Short term use of antipsychotics increases the risk of serious adverse events in elderly people with dementia Short term use of antipsychotics increases the risk of serious adverse events in elderly people with dementia | Evidence-Based Mental Health We use cookies to improve our service and to tailor our content and advertising to you. You can manage your cookie settings via your browser at any time. To learn more about how we use cookies, please see our . Log in using your username (...) and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? Search for this keyword Search for this keyword Main menu Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? You are here Short term use of antipsychotics increases the risk of serious adverse events in elderly people with dementia Article Text Aetiology Short term use of antipsychotics

2009 Evidence-Based Mental Health

198. Vaccine safety and adverse events following immunisation

Vaccine safety and adverse events following immunisation Vaccine safety and the management of adverse events following immunisation August 2012 Green Book Chapter 8 v4_0 53 8 Vaccine safety and the management of adverse events following immunisation Introduction Vaccines induce protection by eliciting active immune responses to specific antigens. There may be predictable adverse reactions (side effects): most are mild and resolve quickly . However, it is not always possible to predict (...) individuals who might have a mild or serious reaction to a vaccine. The advice in this chapter uses the World Health Organization (WHO) classification of adverse events following immunisation (AEFIs). It gives an overview of common side effects associated with vaccines and of the management of serious adverse reactions such as anaphylaxis. The process of vaccine safety monitoring in the UK and the reporting of suspected vaccine-induced adverse drug reactions (ADRs) via the Y ellow Card scheme

2009 The Green Book

199. Meta-analysis: the effect of supplementation with lactoferrin on eradication rates and adverse events during helicobacter pylori eradication therapy

Meta-analysis: the effect of supplementation with lactoferrin on eradication rates and adverse events during helicobacter pylori eradication therapy Untitled Document The CRD Databases will not be available from 08:00 BST on Friday 4th October until 08:00 BST on Monday 7th October for essential maintenance. We apologise for any inconvenience.

2009 DARE.

200. Meta-analysis: the effect and adverse events of Lactobacilli versus placebo in maintenance therapy for Crohn disease

Meta-analysis: the effect and adverse events of Lactobacilli versus placebo in maintenance therapy for Crohn disease Untitled Document The CRD Databases will not be available from 08:00 BST on Friday 4th October until 08:00 BST on Monday 7th October for essential maintenance. We apologise for any inconvenience.

2009 DARE.